Myriad Genetics (MYGN) Operating Margin (2016 - 2025)
Historic Operating Margin for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to 11.33%.
- Myriad Genetics' Operating Margin fell 19500.0% to 11.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 50.95%, marking a year-over-year decrease of 368900.0%. This contributed to the annual value of 14.74% for FY2024, which is 194300.0% up from last year.
- According to the latest figures from Q3 2025, Myriad Genetics' Operating Margin is 11.33%, which was down 19500.0% from 154.48% recorded in Q2 2025.
- In the past 5 years, Myriad Genetics' Operating Margin ranged from a high of 9.38% in Q3 2024 and a low of 154.48% during Q2 2025
- In the last 5 years, Myriad Genetics' Operating Margin had a median value of 18.52% in 2024 and averaged 30.2%.
- Per our database at Business Quant, Myriad Genetics' Operating Margin skyrocketed by 623000bps in 2021 and then crashed by -1372200bps in 2025.
- Myriad Genetics' Operating Margin (Quarter) stood at 26.8% in 2021, then decreased by -10bps to 29.36% in 2022, then soared by 46bps to 15.97% in 2023, then decreased by -16bps to 18.52% in 2024, then surged by 39bps to 11.33% in 2025.
- Its Operating Margin stands at 11.33% for Q3 2025, versus 154.48% for Q2 2025 and 14.8% for Q1 2025.